Abstract
There is increasing evidence that opiates accelerate the pathogenesis and progression of acquired immunodeficiency syndrome (AIDS), as well as the incidence of human immunodeficiency virus (HIV) encephalitis (HIVE), a condition characterized by inflammation, leukocyte infiltration, and microglial activation. The mechanisms, by which the HIV-1 transactivating protein Tat and opioids exacerbate microglial activation, however, are not fully understood. In the current study, we explored the effects of morphine and HIV-1 Tat1–72 on the activation of mouse BV-2 microglial cells and primary mouse microglia. Both morphine and Tat exposure caused up-regulation of the chemokine receptor CCR5, an effect blocked by the opioid receptor antagonist naltrexone. Morphine in combination with Tat also induced morphological changes in the BV-2 microglia from a quiescent to an activated morphology, with a dramatic increase in the expression of the microglial activation marker CD11b, as compared with cells exposed to either agent alone. In addition, the mRNA expression of inducible nitric oxide synthase (iNOS), CD40 ligand, Interferon-gamma-inducible protein 10 (IP-10), and the proinflammatory cytokines tumor necrosis factor alpha (TNFα), interleukin (IL)-1β, and IL-6, which were elevated with Tat alone, were dramatically enhanced with Tat in the presence of morphine. In summary, these findings shed light on the cooperative effects of morphine and HIV-1 Tat on both microglial activation and HIV coreceptor up-regulation, effects that could result in exacerbated neuropathogenesis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adler H, Peterhans E, Jungi TW (1994). Generation and functional characterization of bovine bone marrow-derived macrophages. Vet Immunol Immunopathol 41: 211–227.
Alliot F, Godin I, Pessac B (1999). Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res 117: 145–152.
Bell JE, Donaldson YK, Lowrie S, McKenzie CA, Elton RA, Chiswick A, Brettle RP, Ironside JW, Simmonds P (1996). Influence of risk group and zidovudine therapy on the development of HIV encephalitis and cognitive impairment in AIDS patients. AIDS 10: 493–499.
Bokhari SM, Kim KJ, Pinson DM, Slusser J, Yeh HW, Parmely MJ (2008). NK cells and gamma interferon coordinate the formation and function of hepatic granulomas in mice infected with the Francisella tularensis live vaccine strain. Infect Immun 76: 1379–1389.
Bonwetsch R, Croul S, Richardson MW, Lorenzana C, Del Valle L, Sverstiuk AE, Amini S, Morgello S, Khalili K, Rappaport J (1999). Role of HIV-1 Tat and CC chemokine MIP-1alpha in the pathogenesis of HIV associated central nervous system disorders. J NeuroVirol 5: 685–694.
Budka H (1991). The definition of HIV-specific neuropathology. Acta Pathol Jpn 41: 182–191.
Chao CC, Hu S, Shark KB, Sheng WS, Gekker G, Peterson PK (1997). Activation of mu opioid receptors inhibits microglial cell chemotaxis. J Pharmacol Exp Ther 281: 998–1004.
Chen AC, LaForge KS, Ho A, McHugh PF, Kellogg S, Bell K, Schluger RP, Leal SM, Kreek MJ (2002). Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am J Med Genet 114: 429–435.
D’Aversa TG, Weidenheim KM, Berman JW (2002). CD40-CD40L interactions induce chemokine expression by human microglia: implications for human immunodeficiency virus encephalitis and multiple sclerosis. Am J Pathol 160: 559–567.
D’Aversa TG, Yu KO, Berman JW (2004). Expression of chemokines by human fetal microglia after treatment with the human immunodeficiency virus type 1 protein Tat. J NeuroVirol 10: 86–97.
Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, Littman DR, Dustin ML, Gan WB (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8: 752–758.
de Goer de Herve MG, Delfraissy JF, Taoufik Y (2001). Following direct CD40 activation, human primary microglial cells produce IL-12 p40 but not bioactive IL-12 p70. Cytokine 14: 88–96.
Donahoe RM, Vlahov D (1998). Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83: 77–87.
Fetler L, Amigorena S (2005). Neuroscience. Brain under surveillance: the microglia patrol. Science 309: 392–393.
Fischer-Smith T, Rappaport J (2005). Evolving paradigms in the pathogenesis of HIV-1-associated dementia. Expert Rev Mol Med 7: 1–26.
Garden GA, Guo W, Jayadev S, Tun C, Balcaitis S, Choi J, Montine TJ, Moller T, Morrison RS (2004). HIV associated neurodegeneration requires p53 in neurons and microglia. FASEB J 18: 1141–1143.
Ghafouri M, Amini S, Khalili K, Sawaya BE (2006). HIV-1 associated dementia: symptoms and causes. Retrovirology 3: 28.
Glass JD, Wesselingh SL, Selnes OA, McArthur JC (1993). Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43: 2230–2237.
Gonzalez-Scarano F, Baltuch G (1999). Microglia as mediators of inflammatory and degenerative diseases. Annu Rev Neurosci 22: 219–240.
Grimaldi LM, Martino GV, Franciotta DM, Brustia R, Castagna A, Pristera R, Lazzarin A (1991). Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Ann Neurol 29: 21–25.
Hanisch UK (2002). Microglia as a source and target of cytokines. Glia 40: 140–155.
Kong LY, Wilson BC, McMillian MK, Bing G, Hudson PM, Hong JS (1996). The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol 172: 77–83.
Kruman II, Nath A, Mattson MP (1998). HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp Neurol 154: 276–288.
Ling EA, Wong WC (1993). The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7: 9–18.
Liu B, Du L, Kong LY, Hudson PM, Wilson BC, Chang RC, Abel HH, Hong JS (2000). Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience 97: 749–756.
Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dolle P, Tzavara E, Hanoune J, Roques BP, Kieffer BL (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioidreceptor gene. Nature 383: 819–823.
Nimmerjahn A, Kirchhoff F, Helmchen F (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314–1318.
Pessac B, Godin I, Alliot F (2001). [Microglia: origin and development.] Bull Acad Natl Med 185: 337–346; discussion 346–347.
Pottler M, Zierler S, Kerschbaum HH (2006). An artificial three-dimensional matrix promotes ramification in the microglial cell-line, BV-2. Neurosci Lett 410: 137–140.
Rock RB, Gekker G, Hu S, Sheng WS, Cheeran M, Lokensgard JR, Peterson PK (2004). Role of microglia in central nervous system infections. Clin Microbiol Rev 17: 942–964; table of contents.
Ruzicka BB, Fox CA, Thompson RC, Meng F, Watson SJ, Akil H (1995). Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Brain Res Mol Brain Res 34: 209–220.
Schwarz M, Nordt T, Bode C, Peter K (2002). The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2). Thromb Res 107: 121–128.
Steele AD, Henderson EE, Rogers TJ (2003). Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology 309: 99–107.
Stiene-Martin A, Zhou R, Hauser KF (1998). Regional, developmental, and cell cycle-dependent differences in mu, delta, and kappa-opioid receptor expression among cultured mouse astrocytes. Glia 22: 249–259.
UNAIDS. (2006). report on the global aids epidemic. Geneva: UNAIDS; 2006.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by grants MH62969, RR016443, MH068212, DA020392, and DA024442 from the National Institutes of Health (to S.M.B.).
Rights and permissions
About this article
Cite this article
Bokhari, S.M., Yao, H., Bethel-Brown, C. et al. Morphine enhances Tat-induced activation in murine microglia. Journal of NeuroVirology 15, 219–228 (2009). https://doi.org/10.1080/13550280902913628
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280902913628